MyAverix Finance
F · Healthcare
Cannara Biotech Inc. (8CB0)
Drug Manufacturers - Specialty & Generic
Cannara Biotech Inc. (8CB0) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 8CB0
Cannara Biotech Inc. (8CB0) — FAQ
What is 8CB0's P/E ratio?
The price-to-earnings (P/E) ratio for Cannara Biotech Inc. (8CB0) is 18.00 (data as of 2026-03-24).
Does Cannara Biotech Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Cannara Biotech Inc. (8CB0). Check the MyAverix Finance app for the latest dividend data.
What sector is Cannara Biotech Inc. in?
Cannara Biotech Inc. (8CB0) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 8CB0 listed on?
8CB0 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.